ZHX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.201200E-01
Normal-vs-Stage2
7.254600E-01
Normal-vs-Stage3
6.896000E-02
Normal-vs-Stage4
4.010200E-01
Stage1-vs-Stage2
5.097200E-01
Stage1-vs-Stage3
1.910820E-01
Stage1-vs-Stage4
5.321600E-01
Stage2-vs-Stage3
2.335400E-01
Stage2-vs-Stage4
1.552780E-01
Stage3-vs-Stage4
4.177800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.363000E-01
Normal-vs-AfricanAmerican
9.517400E-01
Normal-vs-Asian
4.522600E-01
Caucasian-vs-AfricanAmerican
7.002400E-01
Caucasian-vs-Asian
4.368800E-01
AfricanAmerican-vs-Asian
3.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.925400E-01
Normal-vs-Female
7.723600E-01
Male-vs-Female
6.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.603000E-01
Normal-vs-Age(41-60Yrs)
8.263200E-01
Normal-vs-Age(61-80Yrs)
7.051600E-01
Normal-vs-Age(81-100Yrs)
5.825400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.663800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.310800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.008800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.608100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.946040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.216000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.153800E-01
Normal-vs-Daily Drinker
4.502400E-01
Normal-vs-Weekly Drinker
7.267200E-01
Normal-vs-Occasional Drinker
7.370600E-01
Normal-vs-Social Drinker
9.343600E-01
Non Drinker-vs-Daily Drinker
9.225800E-01
Non Drinker-vs-Weekly Drinker
5.508600E-01
Non Drinker-vs-Occasional Drinker
3.425700E-02
Non Drinker-vs-Social Drinker
4.313800E-01
Daily Drinker-vs-Weekly Drinker
6.285400E-01
Daily Drinker-vs-Occasional Drinker
6.106400E-02
Daily Drinker-vs-Social Drinker
4.728000E-01
Weekly Drinker-vs-Occasional Drinker
2.589600E-01
Weekly Drinker-vs-Social Drinker
7.529600E-01
Occasional Drinker-vs-Social Drinker
5.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.268200E-01
Normal-vs-Grade 2
1.670580E-01
Normal-vs-Grade 3
1.083620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.719600E-01
Grade 1-vs-Grade 3
9.626400E-01
Grade 1-vs-Grade 4
2.268200E-01
Grade 2-vs-Grade 3
2.620600E-01
Grade 2-vs-Grade 4
1.670580E-01
Grade 3-vs-Grade 4
1.083620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.542200E-01
Normal-vs-NonDiabetic
7.568000E-01
Diabetic-vs-NonDiabetic
7.174000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.294300E-02
Normal-vs-NoPancreatitis
8.076400E-01
Pancreatitis-vs-NoPancreatitis
1.945940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.866800E-01
Normal-vs-N1
7.892800E-01
N0-vs-N1
7.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.461400E-01
Normal-vs-TP53-NonMutant
8.350200E-01
TP53-Mutant-vs-TP53-NonMutant
3.274600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
